Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Return on Capital %

Adverum Biotechnlgs Return on Capital % Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Return on Capital % from 2014 to 2020.
  • Adverum Biotechnlgs Return on Capital % for the quarter ending June 06, 2020 was -22.91 a 5.65% decrease of -1.29 year over year
  • Adverum Biotechnlgs Return on Capital % for the last 12 months ending June 06, 2020 was -21.81 a 15.76% decrease of -3.44 year over year
  • Adverum Biotechnlgs Annual Return on Capital % for 2019 was -20.96 a -12.95% increase of 2.71 from 2018
  • Adverum Biotechnlgs Annual Return on Capital % for 2018 was -23.67 a 23.66% decrease of -5.60 from 2017
  • Adverum Biotechnlgs Annual Return on Capital % for 2017 was -18.07 a 27.36% decrease of -4.94 from 2016
Other Margins & Efficiency Metrics:
  • Adverum Biotechnlgs EBITDA Margin for the quarter ending March 03, 2013 was $-13m
  • Adverum Biotechnlgs Return on Equity % for the quarter ending September 09, 2018 was -37.34 a 13.20% decrease of -4.93 year over year
View Chart On Koyfin

Quarterly ADVM Return on Capital % Data

06/2020-22.91
03/2020-21.90
12/2019-24.62
09/2019-21.62
06/2019-19.28
03/2019-18.90
12/2018-20.09
09/2018-20.57
06/2018-20.75
03/2018-20.84

Annual ADVM Return on Capital % Data

2019-20.96
2018-23.67
2017-18.07
2016-13.13
2015-13.32
2014-20.42
2013550.17